A 25-second eye exam and a cognitive assessment, added to the office cannabis policy. Every combination of tests beat every single test. Free downloads.
The cannabis office policy just got 5 new findings Read More »
Update, August 2026. This policy has been revised since it was published. It now carries a 25-second eye exam and a cognitive assessment, 5 findings that were not in the original. The downloads on this page are the current versions. Here is what changed and why. By David MH Lambert, DDS Half of dentists say
The cannabis patient is already in your chair. Does your office have a policy? Read More »
By David M. Haas Lambert Pick up one of the hemp THC seltzers now sitting in grocery coolers and you’re holding a pharmaceutical drug-delivery system in consumer packaging. I mean that as a formulation claim, not a rhetorical one. And once you see how it’s built, the chairside implications for a dental practice follow directly.
A drug in a can: the pharmaceutics of the THC seltzer, and why it matters chairside Read More »
By David M. Haas Lambert There’s a drug on the grocery shelf right now, sold as a beverage, and it’s worth three minutes of a clinician’s attention before the rules change this November. Not because it’s exotic. Because the gap between how it’s marketed and what it actually is tells you something about how a
The THC seltzer on the grocery shelf: what a clinician should know before it sunsets Read More »
A CE Dojo clinical note A claim keeps circulating in dental circles: clindamycin has no role in dentistry anymore, it’s been pulled from the formulary, there’s no reason to use it. It gets repeated with confidence, usually pointing at the 2021 AHA and ADA update. The confidence is the problem, because the claim folds two
What the 2021 Guidelines Actually Changed About Clindamycin Read More »
Main Menu
User Menu
